We've found
10,154
archived clinical trials in
Other Indications
We've found
10,154
archived clinical trials in
Other Indications
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
Updated: 3/11/2013
A Phase I Study of AC220 for Children With Relapsed or Refractory ALL or AML
Status: Enrolling
Updated: 3/11/2013
Click here to add this to my saved trials
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Updated: 3/12/2013
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Status: Enrolling
Updated: 3/12/2013
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Updated: 3/12/2013
Behavioral Activation/Armodafinil to Treat Fatigue in HIV/AIDS
Status: Enrolling
Updated: 3/12/2013
Click here to add this to my saved trials
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Updated: 3/14/2013
Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia
Status: Enrolling
Updated: 3/14/2013
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
Updated: 3/14/2013
Intranasal Dexmedetomidine Decreases Emergence Delirium in Pediatric Patients After Sevoflurane Based General Anesthesia
Status: Enrolling
Updated: 3/14/2013
Click here to add this to my saved trials
Xylitol Disk Use in Adults With Dry Mouth
Updated: 3/27/2013
XyliMelts Ability to Reduce Mutans Streptococci in Adults With the Perception of Dry Mouth
Status: Enrolling
Updated: 3/27/2013
Xylitol Disk Use in Adults With Dry Mouth
Updated: 3/27/2013
XyliMelts Ability to Reduce Mutans Streptococci in Adults With the Perception of Dry Mouth
Status: Enrolling
Updated: 3/27/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Updated: 5/2/2013
SoundBite Hearing System 24 Month Multi Site Patient Use Study
Status: Enrolling
Updated: 5/2/2013
Click here to add this to my saved trials
The Effect of Nasal Hair on Nasal Obstruction
Updated: 5/7/2013
The Effect of Vibrissae on Subjective and Objective Measures of Nasal Obstruction
Status: Enrolling
Updated: 5/7/2013
The Effect of Nasal Hair on Nasal Obstruction
Updated: 5/7/2013
The Effect of Vibrissae on Subjective and Objective Measures of Nasal Obstruction
Status: Enrolling
Updated: 5/7/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Chronic Pelvic Pain Study of Individuals With Diagnoses or Symptoms of Interstitial Cystitis and/ or Chronic Prostatitis
Updated: 5/14/2013
Multidisciplinary Approach to the Study of Chronic Pelvic Pain: Trans-MAPP Epidemiology and Phenotyping (EP) Study
Status: Enrolling
Updated: 5/14/2013
Click here to add this to my saved trials
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Updated: 5/15/2013
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated: 5/15/2013
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Updated: 5/15/2013
L-carnitine to Treat Fatigue Associated With Crohn's Disease
Status: Enrolling
Updated: 5/15/2013
Click here to add this to my saved trials
Role of Beta-Endorphin in Cancer Therapy Fatigue
Updated: 5/21/2013
Beta-Endorphin as a Mediator of Cancer Therapy-Induced Fatigue
Status: Enrolling
Updated: 5/21/2013
Role of Beta-Endorphin in Cancer Therapy Fatigue
Updated: 5/21/2013
Beta-Endorphin as a Mediator of Cancer Therapy-Induced Fatigue
Status: Enrolling
Updated: 5/21/2013
Click here to add this to my saved trials
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Updated: 5/23/2013
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Status: Enrolling
Updated: 5/23/2013
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Updated: 5/23/2013
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Status: Enrolling
Updated: 5/23/2013
Click here to add this to my saved trials
Neurobehavioral Phenotypes in MPS III
Updated: 6/5/2013
Characterizing the Neurobehavioral Phenotype(s) in MPS III
Status: Enrolling
Updated: 6/5/2013
Neurobehavioral Phenotypes in MPS III
Updated: 6/5/2013
Characterizing the Neurobehavioral Phenotype(s) in MPS III
Status: Enrolling
Updated: 6/5/2013
Click here to add this to my saved trials
Cognitive Training for Firefighters With Tinnitus
Updated: 6/10/2013
Investigating the Impact of Cognitive Training for Firefighters With Tinnitus
Status: Enrolling
Updated: 6/10/2013
Cognitive Training for Firefighters With Tinnitus
Updated: 6/10/2013
Investigating the Impact of Cognitive Training for Firefighters With Tinnitus
Status: Enrolling
Updated: 6/10/2013
Click here to add this to my saved trials
Vitamin D3 Supplementation for Heart Failure Patients
Updated: 6/18/2013
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
Vitamin D3 Supplementation for Heart Failure Patients
Updated: 6/18/2013
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
Click here to add this to my saved trials
Vitamin D3 Supplementation for Heart Failure Patients
Updated: 6/18/2013
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
Vitamin D3 Supplementation for Heart Failure Patients
Updated: 6/18/2013
Double-Blind, Placebo-Controlled Trial of Vitamin D3 (Cholecalciferol) Supplementation for Heart Failure Patients
Status: Enrolling
Updated: 6/18/2013
Click here to add this to my saved trials
Rivastigmine Study in Adolescents With Down Syndrome
Updated: 6/24/2013
A 20-Week Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of Rivastigmine in Children (Ages 10-18) With Down Syndrome
Status: Enrolling
Updated: 6/24/2013
Rivastigmine Study in Adolescents With Down Syndrome
Updated: 6/24/2013
A 20-Week Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of Rivastigmine in Children (Ages 10-18) With Down Syndrome
Status: Enrolling
Updated: 6/24/2013
Click here to add this to my saved trials
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Updated: 6/26/2013
Pilot Study of Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 6/26/2013
Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Updated: 6/26/2013
Pilot Study of Genetically Modified Haploidentical Natural Killer Cell Infusions for B-Lineage Acute Lymphoblastic Leukemia
Status: Enrolling
Updated: 6/26/2013
Click here to add this to my saved trials
A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
Status: Enrolling
Updated: 7/1/2013
Updated: 7/1/2013
A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
Status: Enrolling
Updated: 7/1/2013
Updated: 7/1/2013
Click here to add this to my saved trials
A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
Status: Enrolling
Updated: 7/1/2013
Updated: 7/1/2013
A Non-Drug Study of The Suitability of Neurocognitive Tests And Functioning Scales For The Measurement of Cognitive And Functioning Changes in Individuals With Down Syndrome
Status: Enrolling
Updated: 7/1/2013
Updated: 7/1/2013
Click here to add this to my saved trials
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test
Updated: 7/4/2013
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers
Status: Enrolling
Updated: 7/4/2013
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test
Updated: 7/4/2013
WOUNDCHEK™ Protease Status Point of Care (POC) Diagnostic Test A Prospective, Multi Centre, Randomised, Clinical Study on Venous Leg Ulcers
Status: Enrolling
Updated: 7/4/2013
Click here to add this to my saved trials
A Trial of Magnesium Dependent Tinnitus
Updated: 7/9/2013
A Phase III Trial of Magnesium Dependent Tinnitus
Status: Enrolling
Updated: 7/9/2013
A Trial of Magnesium Dependent Tinnitus
Updated: 7/9/2013
A Phase III Trial of Magnesium Dependent Tinnitus
Status: Enrolling
Updated: 7/9/2013
Click here to add this to my saved trials
Assessment of Vitamin D Supplementation and Immune Function
Updated: 7/18/2013
Assessment of Vitamin D Supplementation and Immune Function
Status: Enrolling
Updated: 7/18/2013
Assessment of Vitamin D Supplementation and Immune Function
Updated: 7/18/2013
Assessment of Vitamin D Supplementation and Immune Function
Status: Enrolling
Updated: 7/18/2013
Click here to add this to my saved trials